We, as the human race, arguably stand on the cusp—or, perhaps, have already embarked on the initial phases—of technological singularity.

Technological advancements, like new technologies for industrial scales and automated systems that are digitalized, allow biopharmaceutical companies to improve the efficiency and accuracy of ...